Laboratory Evaluation of Peripheral Neuropathy

Abstract

Peripheral neuropathy is a common neurological disorder, with high prevalence especially in the aged population. The general evaluative approach is to first identify the type of peripheral neuropathy prior to investigating for a possible underlying etiology, which is an increasingly important endeavor, as many causes of peripheral neuropathy are now recognized as treatable. To this end, laboratory testing plays an important adjunctive role to a detailed history and examination. This review will discuss possible diagnostic laboratory testing pathways for different types of peripheral neuropathy, with the goal of minimizing costs and false-positive results while maximizing the likelihood of identifying a potentially reversible etiology.

Keywords

peripheral neuropathy - laboratory testing - multiple myeloma

• References

• 1 England JD, Gronseth GS, Franklin G. , et al; American Academy of Neurology. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009; 72 (02) 185-192
• 2 Mold JW, Vesely SK, Keyl BA, Schenk JB, Roberts M. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract 2004; 17 (05) 309-318
• 3 Alothman S, Alenazi A, Waitman LR, LeMaster J, Kluding P. Neuropathy and other risk factors for lower extremity amputation in people with diabetes using a clinical data repository system. J Allied Health 2018; 47 (03) 217-221
• 4 Bruce D, Hunter M, Peters K, Davis T, Davis W. Fear of falling is common in patients with type 2 diabetes and is associated with increased risk of falls. Age Ageing 2015; 44 (04) 687-690
• 5 Callaghan BC, Price RS, Chen KS, Feldman EL. The importance of rare subtypes in diagnosis and treatment of peripheral neuropathy: a review. JAMA Neurol 2015; 72 (12) 1510-1518
• 6 Barohn RJ. Approach to peripheral neuropathy and neuronopathy. Semin Neurol 1998; 18 (01) 7-18
• 7 Doughty CT, Seyedsadjadi R. Approach to peripheral neuropathy for the primary care clinician. Am J Med 2018; 131 (09) 1010-1016
• 8 Rison RA, Beydoun SR. Paraproteinemic neuropathy: a practical review. BMC Neurol 2016; 16: 13
• 9 Callaghan B, McCammon R, Kerber K, Xu X, Langa KM, Feldman E. Tests and expenditures in the initial evaluation of peripheral neuropathy. Arch Intern Med 2012; 172 (02) 127-132
• 10 Huan MC. Laboratory evaluation of peripheral neuropathy. Semin Neurol 2010; 30 (04) 337-349
• 11 Levine TD, Saperstein DS. Laboratory evaluation of peripheral neuropathy. Neurol Clin 2013; 31 (02) 363-376
• 12 Willison HJ, Winer JB. Clinical evaluation and investigation of neuropathy. J Neurol Neurosurg Psychiatry 2003; 74 (Suppl. 02) ii3-ii8
• 13 Staff NP, Windebank AJ. Peripheral neuropathy due to vitamin deficiency, toxins, and medications. Continuum (Minneap Minn) 2014; 20 (5 Peripheral Nervous System Disorders): 1293-306
• 14 Lubec D, Müllbacher W, Finsterer J, Mamoli B. Diagnostic work-up in peripheral neuropathy: an analysis of 171 cases. Postgrad Med J 1999; 75 (890) 723-727
• 15 Azhary H, Farooq MU, Bhanushali M, Majid A, Kassab MY. Peripheral neuropathy: differential diagnosis and management. Am Fam Physician 2010; 81 (07) 887-892
• 16 Novella SP, Inzucchi SE, Goldstein JM. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 2001; 24 (09) 1229-1231
• 17 Harrington DJ. Laboratory assessment of vitamin B12 status. J Clin Pathol 2017; 70 (02) 168-173
• 18 Langan RC, Goodbred AJ. Vitamin B12 deficiency: recognition and management. Am Fam Physician 2017; 96 (06) 384-389
• 19 Shandal V, Luo JJ. Clinical manifestations of isolated elevated homocysteine-induced peripheral neuropathy in adults. J Clin Neuromuscul Dis 2016; 17 (03) 106-109
• 20 Smith J, Raines G, Schneider HG. A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum. Clin Chem Lab Med 2018; 56 (02) 256-263
• 21 Katzmann JA, Kyle RA, Benson J. , et al. Screening panels for detection of monoclonal gammopathies. Clin Chem 2009; 55 (08) 1517-1522
• 22 Reda H, Chin RL. Peripheral neuropathies of rheumatologic disease and gluten-related disorders. Semin Neurol 2014; 34 (04) 413-424
• 23 Gabbai AA, Castelo A, Oliveira AS. HIV peripheral neuropathy. Handb Clin Neurol 2013; 115: 515-529
• 24 Hehir II MK, Logigian EL. Infectious neuropathies. Continuum (Minneap Minn) 2014; 20 (5 Peripheral Nervous System Disorders): 1274-1292
• 25 Ungprasert P, Matteson EL. Neurosarcoidosis. Rheum Dis Clin North Am 2017; 43 (04) 593-606
• 26 Jann S, Beretta S, Bramerio M, Defanti CA. Prospective follow-up study of chronic polyneuropathy of undetermined cause. Muscle Nerve 2001; 24 (09) 1197-1201
• 27 Mathis S, Magy L, Le Masson G. , et al. Value of nerve biopsy in the management of peripheral neuropathies. Expert Rev Neurother 2018; 18 (07) 589-602
• 28 Allen JA. Chronic demyelinating polyneuropathies. Continuum (Minneap Minn) 2017; 23 (5, Peripheral Nerve and Motor Neuron Disorders): 1310-1331
• 29 Minagar A. GALOP syndrome: a treatable immune-mediated late-age onset polyneuropathy with gait ataxia. South Med J 2004; 97 (04) 333-334
• 30 Nyboe Andersen N, Pasternak B, Andersson M, Nielsen NM, Jess T. Risk of demyelinating diseases in the central nervous system in patients with inflammatory bowel disease treated with tumor necrosis factor inhibitors. JAMA Intern Med 2015; 175 (12) 1990-1992
• 31 Illes Z, Blaabjerg M. Cerebrospinal fluid findings in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathies. Handb Clin Neurol 2017; 146: 125-138
• 32 Querol L, Siles AM, Alba-Rovira R. , et al. Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy. Sci Rep 2017; 7 (01) 14411
• 33 Querol L, Nogales-Gadea G, Rojas-Garcia R. , et al. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology 2014; 82 (10) 879-886
• 34 Kuwahara M, Suzuki H, Samukawa M, Hamada Y, Takada K, Kusunoki S. Clinical features of CIDP with LM1-associated antibodies. J Neurol Neurosurg Psychiatry 2013; 84 (05) 573-575
• 35 Verschueren A. Immune-mediated neuropathies: indications and value of nerve biopsy. Rev Neurol (Paris) 2007; 163 Spec No 1: 3S58-3S60
• 36 Galban-Horcajo F, Vlam L, Delmont E. , et al. The diagnostic utility of determining anti-GM1: GalC complex antibodies in multifocal motor neuropathy: a validation study. J Neuromuscul Dis 2015; 2 (02) 157-165
• 37 Delmont E, Halstead S, Galban-Horcajo F, Yao D, Desnuelle C, Willison H. Improving the detection of IgM antibodies against glycolipids complexes of GM1 and galactocerebroside in multifocal motor neuropathy using glycoarray and ELISA assays. J Neuroimmunol 2015; 278: 159-161
• 38 Pestronk A, Chuquilin M, Choksi R. Motor neuropathies and serum IgM binding to NS6S heparin disaccharide or GM1 ganglioside. J Neurol Neurosurg Psychiatry 2010; 81 (07) 726-730
• 39 Nobile-Orazio E, Giannotta C, Musset L, Messina P, Léger JM. Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 2014; 85 (07) 754-758
• 40 Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol 2011; 69 (01) 22-33
• 41 GeneDx. Neurology Genetics. Available at: https://www.genedx.com/test-catalog/medical-specialty/neurology/ . Accessed May 9, 2019
• 42 GeneDx. GeneDx Neurology Test Requisition Form. Available at: https://www.genedx.com/wp-content/uploads/crm_docs/67148-Neurology-Test-Req-var_final.pdf . Accessed August 20, 2018
• 43 Dalakas MC. Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies. Ther Adv Neurol Disorder 2018; 11: 1756285617746640
• 44 Kuijf ML, Eurelings M, Tio-Gillen AP. , et al. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy. Neurology 2009; 73 (09) 688-695
• 45 Keddie S, D'Sa S, Foldes D, Carr AS, Reilly MM, Lunn MPT. POEMS neuropathy: optimising diagnosis and management. Pract Neurol 2018; 18 (04) 278-290
• 46 Verschueren A. Motor neuropathies and lower motor neuron syndromes. Rev Neurol (Paris) 2017; 173 (05) 320-325
• 47 Stojkovic T. Hereditary neuropathies: an update. Rev Neurol (Paris) 2016; 172 (12) 775-778
• 48 Zis P, Hadjivassiliou M, Sarrigiannis PG, Barker ASJE, Rao DG. Rapid neurophysiological screening for sensory ganglionopathy: a novel approach. Brain Behav 2017; 7 (12) e00880
• 49 Pereira PR, Viala K, Maisonobe T. , et al. Sjögren sensory neuronopathy (Sjögren ganglionopathy): long-term outcome and treatment response in a series of 13 cases. Medicine (Baltimore) 2016; 95 (19) e3632
• 50 Zis P, Rao DG, Sarrigiannis PG. , et al. Transglutaminase 6 antibodies in gluten neuropathy. Dig Liver Dis 2017; 49 (11) 1196-1200
• 51 Antoine JC, Camdessanché JP. Paraneoplastic neuropathies. Curr Opin Neurol 2017; 30 (05) 513-520
• 52 Malek E, Doumiati H, Salameh JS. Pyridoxine-induced sensory ataxic ganglionopathy: a case report and literature review. Acta Neurol Belg 2018 . doi: 10.1007/s13760-018-0919-7
• 53 Esiri MM, Morris CS, Millard PR. Sensory and sympathetic ganglia in HIV-1 infection: immunocytochemical demonstration of HIV-1 viral antigens, increased MHC class II antigen expression and mild reactive inflammation. J Neurol Sci 1993; 114 (02) 178-187
• 54 Alix JJ, Alam T, Garrard K. , et al. Variable sensory nerve conduction parameters in late onset Friedreich ataxia. Muscle Nerve 2017; 55 (02) E7-E8
• 55 Gorson KC, Ropper AH. Positive salivary gland biopsy, Sjögren syndrome, and neuropathy: clinical implications. Muscle Nerve 2003; 28 (05) 553-560
• 56 Birnbaum J. Peripheral nervous system manifestations of Sjögren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies. Neurologist 2010; 16 (05) 287-297
• 57 Guarner J. Human immunodeficiency virus: diagnostic approach. Semin Diagn Pathol 2017; 34 (04) 318-324
• 58 Wallace SE, Bird TD. Molecular genetic testing for hereditary ataxia: what every neurologist should know. Neurol Clin Pract 2018; 8 (01) 27-32
• 59 Gibbons CH. Small fiber neuropathies. Continuum (Minneap Minn) 2014; 20 (5 Peripheral Nervous System Disorders): 1398-1412
• 60 Brouwer BA, Bakkers M, Hoeijmakers JG, Faber CG, Merkies IS. Improving assessment in small fiber neuropathy. J Peripher Nerv Syst 2015; 20 (03) 333-340
• 61 Treister R, O'Neil K, Downs HM, Oaklander AL. Validation of the composite autonomic symptom scale 31 (COMPASS-31) in patients with and without small fiber polyneuropathy. Eur J Neurol 2015; 22 (07) 1124-1130
• 62 Lauria G, Cornblath DR, Johansson O. , et al; European Federation of Neurological Societies. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol 2005; 12 (10) 747-758
• 63 Seger S, Stritt M, Doppler K. , et al. A semi-automated method to assess intraepidermal nerve fibre density in human skin biopsies. Histopathology 2016; 68 (05) 657-665
• 64 Provitera V, Gibbons CH, Wendelschafer-Crabb G. , et al. The role of skin biopsy in differentiating small-fiber neuropathy from ganglionopathy. Eur J Neurol 2018; 25 (06) 848-853
• 65 Boruchow SA, Gibbons CH. Utility of skin biopsy in management of small fiber neuropathy. Muscle Nerve 2013; 48 (06) 877-882
• 66 Backonja MM, Attal N, Baron R. , et al. Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain 2013; 154 (09) 1807-1819
• 67 Siao P, Cros DP. Quantitative sensory testing. Phys Med Rehabil Clin N Am 2003; 14 (02) 261-286
• 68 Buchmann SJ, Penzlin AI, Kubasch ML, Illigens BM, Siepmann T. Assessment of sudomotor function. Clin Auton Res 2019; 29 (01) 41-53
• 69 Berger MJ, Kimpinski K. Test-retest reliability of quantitative sudomotor axon reflex testing. J Clin Neurophysiol 2013; 30 (03) 308-312
• 70 Rajan S, Campagnolo M, Callaghan B, Gibbons CH. Sudomotor function testing by electrochemical skin conductance: does it really measure sudomotor function?. Clin Auton Res 2019; 29 (01) 31-39
• 71 Blackmore D, Siddiqi ZA. Diagnostic criteria for small fiber neuropathy. J Clin Neuromuscul Dis 2017; 18 (03) 125-131
• 72 Cygankiewicz I, Zareba W. Heart rate variability. Handb Clin Neurol 2013; 117: 379-393
• 73 Mckeon A, Benarroch EE. Autoimmune autonomic disorders. Handb Clin Neurol 2016; 133: 405-416
• 74 Yozu A, Haga N, Funato T, Owaki D, Chiba R, Ota J. Hereditary sensory and autonomic neuropathy types 4 and 5: review and proposal of a new rehabilitation method. Neurosci Res 2016; 104: 105-111
• 75 Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000; 48 (04) 624-631
• 76 Carod-Artal FJ. Neurological complications of Zika virus infection. Expert Rev Anti Infect Ther 2018; 16 (05) 399-410
• 77 Teener JW. Miller Fisher's syndrome. Semin Neurol 2012; 32 (05) 512-516
• 78 Taams NE, Notermans NC, Fokkink WR, Tio-Gillen AP, Huizinga R, Schreurs MW, Jacobs BC. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies. J Peripher Nerv Syst 2018; 23 (04) 227-234
• 79 Solomon T, Willison H. Infectious causes of acute flaccid paralysis. Curr Opin Infect Dis 2003; 16 (05) 375-381
• 80 Leis AA, Stokic DS, Webb RM, Slavinski SA, Fratkin J. Clinical spectrum of muscle weakness in human West Nile virus infection. Muscle Nerve 2003; 28 (03) 302-308
• 81 Fooks AR, Cliquet F, Finke S. , et al. Rabies. Nat Rev Dis Primers 2017; 3: 17091
• 82 Dürr S, Naïssengar S, Mindekem R. , et al. Rabies diagnosis for developing countries. PLoS Negl Trop Dis 2008; 2 (03) e206
• 83 Wu CL, Ro LS, Jung SM. , et al. Clinical presentation and electrophysiological findings of porphyric neuropathies: a follow-up study. Muscle Nerve 2015; 51 (03) 363-369
• 84 Woolf J, Marsden JT, Degg T. , et al. Best practice guidelines on first-line laboratory testing for porphyria. Ann Clin Biochem 2017; 54 (02) 188-198
• 85 Sommer C. Nerve and skin biopsy in neuropathies. Curr Opin Neurol 2018; 31 (05) 534-540
• 86 England JD, Gronseth GS, Franklin G. , et al; American Academy of Neurology. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009; 72 (02) 177-184
• 87 Zhang YS, Sun AP, Chen L, Dong RF, Zhong YF, Zhang J. Nerve biopsy findings contribute to diagnosis of multiple mononeuropathy: 78% of findings support clinical diagnosis. Neural Regen Res 2015; 10 (01) 112-118
• 88 Levin SN, Lyons JL. Infections of the nervous system. Am J Med 2018; 131 (01) 25-32
• 89 Breda S, Richter HP, Schachenmayr W. [Incidence of biopsy-detectable amyloid deposits in the retinaculum flexorum and in the tenosynovial tissue in carpal tunnel syndrome]. Zentralbl Neurochir 1993; 54 (02) 72-76
• 90 Tracy JA, Dyck PJ, Dyck PJ. Primary amyloidosis presenting as upper limb multiple mononeuropathies. Muscle Nerve 2010; 41 (05) 710-715
• 91 Galant NJ, Westermark P, Higaki JN, Chakrabartty A. Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy. Clin Sci (Lond) 2017; 131 (05) 395-409
• 92 Shobha N, Taly AB, Sinha S, Venkatesh T. Radial neuropathy due to occupational lead exposure: phenotypic and electrophysiological characteristics of five patients. Ann Indian Acad Neurol 2009; 12 (02) 111-115
• 93 Dsouza HS, Dsouza SA, Menezes G, Thuppil V. Evaluation and treatment of wrist drop in a patient due to lead poisoning: case report. Ind Health 2009; 47 (06) 677-680
• 94 Verhagen WI, Gabreëls-Festen AA, van Wensen PJ. , et al. Hereditary neuropathy with liability to pressure palsies: a clinical, electroneurophysiological and morphological study. J Neurol Sci 1993; 116 (02) 176-184
• 95 Robert-Varvat F, Jousserand G, Bouhour F. , et al. Hereditary neuropathy with liability to pressure palsy in patients under 30 years old: neurophysiological data and proposed electrodiagnostic criteria. Muscle Nerve 2018; 57 (02) 217-221
• 96 Park JE, Noh SJ, Oh M, Cho DY, Kim SY, Ki CS. Frequency of hereditary neuropathy with liability to pressure palsies (HNPP) due to 17p11.2 deletion in a Korean newborn population. Orphanet J Rare Dis 2018; 13 (01) 40